EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genome stability disrupted by the circRBM39(4,5,6)–RPA2 axis represses breast tumorigenesis

Xing Bian, Maoyi Xu iD, Na Li, Chuanbo Sun, Xu Liu, Yuqi Deng, Dun Liu, Guozhen Cao iD, Wenchu Lin, Bo Hong iD, Ge Shan iD, Xiaolin Wang iD

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2614237123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Xing Bian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of University of Science and Technology of China, The Ribonucleic Acid Institu…. Hauptthemen laut MEDLINE: Genomic Instability, Breast Neoplasms, Replication Protein A, RNA, Circular. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome instability (GI) is a hallmark of cancer. GI is associated with accumulative DNA damage and tumor-specific defects in DNA repair. Multiple antitumor drugs have been developed to promote persistent GI and to drive DNA damage beyond a threshold that tumor cells can survive. However, regulatory roles of circular RNAs (circRNAs) in GI and DNA damage remain elusive. Through circRNA profiling and a small interfering RNA (siRNA)-mediated screen, we have identified a circRNA termed circRBM39(4,5,6) , which is significantly decreased in breast cancer (BC) and disrupts DNA damage response. CircRBM39(4,5,6) inhibits breast tumorigenesis through increasing DNA damage and promoting sensitivity to the antitumor drug poly Adenosine Diphosphate (ADP-ribose) polymerase inhibitor (PARPi). Mechanistically, cytoplasmic circRBM39(4,5,6) interacts with replication protein A2 (RPA2), an essential DNA repair factor, through a 7-nt AG-rich motif and destabilizes RPA2 protein by facilitating HECT and RCC1-like domain 2 (HERC2)-mediated ubiquitination, thus repressing homologous recombination repair. Importantly, administration of in vitro synthesized circRBM39(4,5,6) substantially inhibits breast tumorigenesis, sensitizes BC cells to PARPi, and renders them susceptible to synthetic lethality (SL) in distinct breast tumorigenesis mouse models. Our findings highlight the interplay between circRNA and GI in cancers, and the SL of circRBM39(4,5,6) to PARPi provides strategies for RNA-based BC therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genomic InstabilityBreast NeoplasmsReplication Protein ARNA, CircularCarcinogenesisHumansFemaleAnimalsMiceDNA DamageCell Line, TumorGene Expression Regulation, NeoplasticDNA RepairPoly(ADP-ribose) Polymerase Inhibitors

Stichwörter der Autor:innen

PARP inhibitionRPA2breast cancercircRBM39(4,5,6)genome instability

Substanzen

Replication Protein ARNA, CircularRPA2 protein, humanPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of University of Science and Technology of China, The Ribonucleic Acid Institute, School of Basic Medical Sciences, Division of Life Science and Med…
  • Center for Advanced Interdisciplinary Science and Biomedicine of Institute of Healthand Medicine, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230027, China.
  • College of Life and Health, West Anhui University, Lu'an 237012, China.
  • Department of Medical Oncology, The Affiliated Hospital of Jiaxing University, Jiaxing 314001, China.
  • Department of Pathology, Jiaxing Maternity and Child Health Hospital, Affiliated Women and Children's Hospital of Jiaxing University, Jiaxing Affiliated Women and Children's Hospital of Wenzhou Medical University, Jiaxi…
  • Institute of Digestive Disease, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen and Longgang District People's Hospital of Shenzhen, Shenzhen 518172, China.

ORCID-Profile: Maoyi Xu, Guozhen Cao, Bo Hong, Ge Shan, Xiaolin Wang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Bian, X., Xu, M., Li, N., Sun, C., Liu, X., Deng, Y., Liu, D., Cao, G., Lin, W., Hong, B., Shan, G., & Wang, X. (2026). Genome stability disrupted by the circRBM39(4,5,6)–RPA2 axis represses breast tumorigenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2614237123

Vancouver

Bian X, Xu M, Li N, Sun C, Liu X, Deng Y, et al. Genome stability disrupted by the circRBM39(4,5,6)–RPA2 axis represses breast tumorigenesis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2614237123

BibTeX
@article{Bian2026,
  author = {Bian, Xing and Xu, Maoyi and Li, Na and Sun, Chuanbo and Liu, Xu and Deng, Yuqi and Liu, Dun and Cao, Guozhen and Lin, Wenchu and Hong, Bo and Shan, Ge and Wang, Xiaolin},
  title = {Genome stability disrupted by the circRBM39(4,5,6)–RPA2 axis represses breast tumorigenesis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2614237123}
}
Kostenlos starten →